DrugDashboards

Geodon

ziprasidone hydrochloride · ZIPRASIDONE HYDROCHLORIDE 60 mg/1 · Capsule · Oral · Roerig

NDC 00049-0056-60 · 60 CAPSULE in 1 BOTTLE · NDA · View full market →

The short version

9 companies supply this market — a reasonable cushion if one runs into trouble.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Part D plans paid (avg)$27.89per dosage unitgross, before rebates — matched by drug name · 2024
  • Medicaid generic ceiling (FUL)$0.5305per CAPweighted avg manufacturer price $0.3032 · Aug 1, 2022

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for ziprasidone hydrochloride (oral solid) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $2,057.35 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
NDA020825
TE code
AB
Approval date
Feb 5, 2001
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

  • Class II · TerminatedApr 13, 2022
    Mckesson Medical-Surgical Inc. Corporate Office — cGMP deviations: Temperature abuse

Manufacturers of ziprasidone hydrochloride (Capsule)

LabelerStrengthFirst seenLast seen
Aurobindo Pharma LimitedZIPRASIDONE HYDROCHLORIDE 40 mg/1Jul 15, 2026Sep 3, 2026
Bryant Ranch PrepackZIPRASIDONE HYDROCHLORIDE 80 mg/1Jul 15, 2026Sep 3, 2026
Pfizer Ireland Pharmaceuticals Unlimited CompanyZIPRASIDONE HYDROCHLORIDE 20 mg/1Jul 15, 2026Sep 3, 2026
Pfizer Ireland Pharmaceuticals Unlimited CompanyZIPRASIDONE HYDROCHLORIDE 80 mg/1Jul 15, 2026Sep 3, 2026
A-S Medication SolutionsZIPRASIDONE HYDROCHLORIDE 40 mg/1Jul 15, 2026Sep 2, 2026
BluePoint LaboratoriesZIPRASIDONE HYDROCHLORIDE 60 mg/1Jul 15, 2026Sep 2, 2026
BluePoint LaboratoriesZIPRASIDONE HYDROCHLORIDE 80 mg/1Jul 15, 2026Sep 2, 2026
BluePoint LaboratoriesZIPRASIDONE HYDROCHLORIDE 20 mg/1Jul 15, 2026Sep 2, 2026
BluePoint LaboratoriesZIPRASIDONE HYDROCHLORIDE 40 mg/1Jul 15, 2026Sep 2, 2026
Bryant Ranch PrepackZIPRASIDONE HYDROCHLORIDE 20 mg/1Jul 15, 2026Sep 2, 2026
Macleods Pharmaceuticals LimitedZIPRASIDONE HYDROCHLORIDE 40 mg/1Jul 15, 2026Sep 2, 2026
Macleods Pharmaceuticals LimitedZIPRASIDONE HYDROCHLORIDE 80 mg/1Jul 15, 2026Sep 2, 2026
Macleods Pharmaceuticals LimitedZIPRASIDONE HYDROCHLORIDE 20 mg/1Jul 15, 2026Sep 2, 2026
Macleods Pharmaceuticals LimitedZIPRASIDONE HYDROCHLORIDE 60 mg/1Jul 15, 2026Sep 2, 2026
NuCare Pharmaceuticals,Inc.ZIPRASIDONE HYDROCHLORIDE 40 mg/1Jul 15, 2026Sep 2, 2026
NuCare Pharmaceuticals,Inc.ZIPRASIDONE HYDROCHLORIDE 20 mg/1Jul 15, 2026Sep 2, 2026
Pfizer Ireland Pharmaceuticals Unlimited CompanyZIPRASIDONE HYDROCHLORIDE 60 mg/1Jul 15, 2026Sep 2, 2026
Remedyrepack Inc.ZIPRASIDONE HYDROCHLORIDE 60 mg/1Jul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedZIPRASIDONE HYDROCHLORIDE 60 mg/1Jul 15, 2026Aug 31, 2026
Bryant Ranch PrepackZIPRASIDONE HYDROCHLORIDE 40 mg/1Jul 15, 2026Aug 31, 2026
Bryant Ranch PrepackZIPRASIDONE HYDROCHLORIDE 60 mg/1Jul 15, 2026Aug 31, 2026
Pfizer Ireland Pharmaceuticals Unlimited CompanyZIPRASIDONE HYDROCHLORIDE 40 mg/1Jul 15, 2026Aug 31, 2026
Remedyrepack Inc.ZIPRASIDONE HYDROCHLORIDE 40 mg/1Jul 15, 2026Aug 29, 2026
Aurobindo Pharma LimitedZIPRASIDONE HYDROCHLORIDE 20 mg/1Jul 15, 2026Aug 28, 2026
Aurobindo Pharma LimitedZIPRASIDONE HYDROCHLORIDE 80 mg/1Jul 15, 2026Aug 28, 2026
Remedyrepack Inc.ZIPRASIDONE HYDROCHLORIDE 20 mg/1Jul 15, 2026Aug 28, 2026
RoerigZIPRASIDONE HYDROCHLORIDE 80 mg/1Jul 15, 2026Aug 12, 2026
RoerigZIPRASIDONE HYDROCHLORIDE 60 mg/1Jul 15, 2026Aug 12, 2026
Remedyrepack Inc.ZIPRASIDONE HYDROCHLORIDE 80 mg/1Jul 15, 2026Jul 22, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Geodon — NDC 00049-0056-60," retrieved September 3, 2026, https://drugdashboards.com/drug/00049005660.

Free to cite with attribution — see how the data is put together.